Edwards Lifesciences (EW) insider files to sell 45,360 shares under Rule 144

Rhea-AI Filing Summary

Edwards Lifesciences insider Donald E. Bobo Jr. has filed a notice to sell company stock under Rule 144. The planned sale covers 45,360 shares of common stock through broker Charles Schwab & Co., Inc., with an aggregate market value of $3,885,715.00, and relates to an employee stock option exercise using a broker-assisted cashless exercise. The filing notes that 580,300,000 shares of Edwards Lifesciences common stock are outstanding and lists the New York Stock Exchange as the trading venue.

The notice also reports that over the past three months, the same insider sold 11,340 Edwards Lifesciences shares on 12/10/2025 for gross proceeds of $950,582.00 and 11,387 shares on 12/12/2025 for gross proceeds of $953,748.00. By signing the form, the seller represents that he is not aware of any undisclosed material adverse information about the company’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	45360	3885715.00	580300000	01/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/06/2026	Employee Stock Option Exercise - See Remarks	EDWARDS LIFESCIENCES CORPORATION			45360	01/06/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DONALD E BOBO JR ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	12/10/2025	11340	950582.00
DONALD E BOBO JR ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	12/12/2025	11387	953748.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Edwards Lifesciences (EW) Form 144 filing disclose?

The Form 144 filing discloses that Donald E. Bobo Jr. intends to sell 45,360 shares of Edwards Lifesciences common stock through Charles Schwab & Co., Inc. on the NYSE, with an aggregate market value of $3,885,715.00, following an employee stock option exercise handled as a broker-assisted cashless exercise.

How many Edwards Lifesciences (EW) shares are planned to be sold and at what value?

The filing reports that 45,360 common shares of Edwards Lifesciences are to be sold, with an aggregate market value of $3,885,715.00, through broker Charles Schwab & Co., Inc.

How were the Edwards Lifesciences (EW) shares being sold under Form 144 acquired?

The shares were acquired via an employee stock option exercise, described as “Employee Stock Option Exercise - See Remarks,” with broker payment for cashless exercise listed as the nature of payment, all dated 01/06/2026.

What recent Edwards Lifesciences (EW) stock sales by the insider are reported?

Over the past three months, the filing reports that Donald E. Bobo Jr. sold 11,340 shares on 12/10/2025 for gross proceeds of $950,582.00 and 11,387 shares on 12/12/2025 for gross proceeds of $953,748.00.

How many Edwards Lifesciences (EW) shares are outstanding according to the filing?

The Form 144 states that there are 580,300,000 shares of Edwards Lifesciences common stock outstanding.

What representation does the insider make in the Edwards Lifesciences (EW) Form 144?

By signing the notice, the seller represents that he does not know any material adverse information about the current and prospective operations of Edwards Lifesciences that has not been publicly disclosed.